Literature DB >> 30946292

Inter-Rater Reliability Between Critical Care Nurses Performing a Pediatric Modification to the Glasgow Coma Scale.

Matthew P Kirschen1,2,3, Megan Snyder4, Katherine Smith4, Kristen Lourie4, Kenya Agarwal4, Pamela DiDonato4, Ashlee Doll4, Bingqing Zhang1, Janell Mensinger5, Rebecca Ichord2,3, Judy A Shea6, Robert A Berg1,3, Vinay Nadkarni1,3, Alexis Topjian1,3.   

Abstract

OBJECTIVES: Estimate the inter-rater reliability of critical care nurses performing a pediatric modification of the Glasgow Coma Scale in a contemporary PICU.
DESIGN: Prospective observation study.
SETTING: Large academic PICU. PATIENTS/
SUBJECTS: All 274 nurses with permanent assignments in the PICU were eligible to participate. A subset of 18 nurses were selected as study registered nurses. All PICU patients were eligible to participate.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: PICU nurses were educated and demonstrated proficiency on a pediatric modification of the Glasgow Coma Scale we created to make it more applicable to a diverse PICU population that included patients who are sedated, mechanically ventilated, and/or have developmental disabilities. Each study registered nurse observed a sample of nurses perform the Glasgow Coma Scale, and they independently scored the Glasgow Coma Scale. Patients were categorized as having developmental disabilities if their preillness Pediatric Cerebral Performance Category score was greater than or equal to 3. Fleiss' Kappa (κ), intraclass correlation coefficient, and percent agreement assessed inter-rater reliability for each Glasgow Coma Scale component (eye, verbal, motor) and age-specific scale (≥ 2 and < 2-yr-old). The overall percent agreement between study registered nurses and nurses was 89% for the eye, 91% for the verbal, and 79% for the motor responses. Inter-rater reliability ranged from good (intraclass correlation coefficient = 0.75) to excellent (intraclass correlation coefficient = 0.96) for testable patients. Agreement on the motor response was significantly lower for children with developmental disabilities (< 2 yr: 59% vs 95%; p = 0.0012 and ≥ 2 yr: 55% vs 91%; p = 0.0012). Agreement was significantly worse for intermediate range Glasgow Coma Scale motor responses compared with responses at the extremes (e.g., motor responses 2, 3, 4 vs 1, 5, 6; p < 0.05).
CONCLUSIONS: A pediatric modification of the Glasgow Coma Scale performed by trained PICU nurses has excellent inter-rater reliability, although reliability was reduced in patients with developmental disabilities and for intermediate range Glasgow Coma Scale responses. Further research is needed to determine the effectiveness of this Glasgow Coma Scale modification to detect clinical deterioration.

Entities:  

Mesh:

Year:  2019        PMID: 30946292     DOI: 10.1097/PCC.0000000000001938

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  3 in total

Review 1.  The brain in pediatric critical care: unique aspects of assessment, monitoring, investigations, and follow-up.

Authors:  Kate L Brown; Shruti Agrawal; Matthew P Kirschen; Chani Traube; Alexis Topjian; Ronit Pressler; Cecil D Hahn; Barnaby R Scholefield; Hari Krishnan Kanthimathinathan; Aparna Hoskote; Felice D'Arco; Melania Bembea; Joseph C Manning; Maayke Hunfeld; Corinne Buysse; Robert C Tasker
Journal:  Intensive Care Med       Date:  2022-04-21       Impact factor: 17.440

2.  Outcomes Associated With Timing of Neurologic Dysfunction Onset Relative to Pediatric Sepsis Recognition.

Authors:  Alicia M Alcamo; Scott L Weiss; Julie C Fitzgerald; Matthew P Kirschen; Laura L Loftis; Swee Fong Tang; Neal J Thomas; Vinay M Nadkarni; Sholeen T Nett
Journal:  Pediatr Crit Care Med       Date:  2022-05-03       Impact factor: 3.971

3.  Nontraumatic coma in the pediatric intensive care unit: etiology, clinical characteristics and outcome

Authors:  Muhterem Duyu; Zeynep Karakaya Altun; Selİn Yildiz
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.